This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Diane Retallack, PhD
President & COO at Primrose Bio
Speaker

Profile

Diane was a founding member of the team that established the Pfenex Expression Technology® platform, overseeing strain engineering, HTP screening, and upstream development. With over 25 years of experience in molecular biology, protein expression and executive management, she has contributed to multiple therapeutic programs from product conception through commercialization. Diane completed her doctorate at the University of Michigan and post-doctoral work at the University of Wisconsin-Madison.

Agenda Sessions

  • Streamlined Antibody and Therapeutic Development Using The Pfenex Expression Technology® Platform

    12:05pm